XML 34 R23.htm IDEA: XBRL DOCUMENT v3.24.3
EQUITY (Tables)
9 Months Ended
Sep. 30, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
SCHEDULE OF STOCK WARRANTS OUTSTANDING TO PURCHASE COMMON STOCK

As of September 30, 2024, the Company had the following outstanding warrants to purchase common stock:

 

         Exercise Price   Number of 
   Issuance  Expiration  Per Share   Underlying 
Warrant  Date  Date  ($)   Common Stocks 
               
March 2021 Warrants  March 29, 2021  March 31, 2026   10.35    2,469,156 
March 2023 Warrants  March 27, 2023  March 26, 2026   5.50    3,294,117 
               5,763,273 
SCHEDULE OF FAIR VALUE OF OPTIONS ESTIMATED ASSUMPTIONS

The fair value of each option was estimated as of the date of grant or reporting period using the Black-Scholes option-pricing model, using the following assumptions:

 

   Nine months ended 
   September 30, 2024 
Underlying value of ordinary shares ($)   5.55-5.70 
Exercise price ($)   4.5-4.8 
Expected volatility (%)   101%
Term of the options (years)   7 
Risk-free interest rate   3.51%-4.23%
SCHEDULE OF STOCK OPTION ACTIVITY

The following table summarizes stock option activity for the nine months ended September 30, 2024:

 

   For the 
   Nine months ended 
   September 30, 2024 
       Weighted 
       average 
   Number of   exercise 
   Options   price 
         $ 
Outstanding at beginning of period   2,455,069    3.46 
Granted   760,500    4.76 
Forfeited   (23,335)   3 
Outstanding at end of period   3,192,234    3.77 
           
Vested at end of period   1,573,336    3.47 
SCHEDULE OF STOCK-BASED PAYMENT EXPENSE

The following table sets forth the total stock-based payment expenses resulting from options and RSUs granted, included in the statements of operation and comprehensive income:

 

   2024   2023   2024   2023 
  

Nine months ended

September 30,

  

Three months ended

September 30,

 
   2024   2023   2024   2023 
   Unaudited 
   USD in thousands 
                 
Cost of revenues   23    11    6    6 
Research and development   402    323    177    58 
Sales and marketing expenses   151    83    56    21 
General and administrative   924    639    298    286 
Total expenses   1,500    1,056    537    371 
Restricted Stock [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
SCHEDULE OF STOCK OPTION ACTIVITY

The following table summarizes RSU activity for the nine months ended September 30, 2024:

 

   For the 
   Nine months ended 
   September 30, 2024 
       Weighted Average 
   Number of   Grant Date Fair Value 
   RSUs   per Share 
         $ 
Outstanding at beginning of period   39,585    4.08 
Granted   -    - 
Forfeited   -    - 
Vested   (19,165)   4.34 
Unvested and Outstanding at end of period   20,420    3.84